LIGAND PHARM Financial Diagnostics

Macroaxis technical analysis interface lets you check helpful technical drivers of LIGAND PHARM INC as well as the relationship between them. The company executives did not add any value to LIGAND PHARM INC investors in June. However, most investors can still diversify their portfolios with LIGAND PHARM INC to hedge your portfolio against high-volatility market scenarios. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 0.0. The very small Stock volatility is a good signal to investors with longer term investment horizons. This diagnostics interface makes it easy to digest most current publicly released information about LIGAND PHARM as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis LIGAND PHARM price relationship with some important fundamental indicators such as market cap and management efficiency. See also Stocks Correlation.

LIGAND PHARM Note

The company had not issued any dividends in recent years.

LIGAND PHARM INC Alerts

LIGAND PHARM INC is not yet fully synchronised with the market data
LIGAND PHARM INC has some characteristics of a very speculative penny stock

LIGAND PHARM Technical and Predictive Indicators

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module
See also Stocks Correlation. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.
Search macroaxis.com